On 16 June 2026, the 3rd Governmental Advisory Board (GAB) meeting of the EUCanScreen Joint Action was held online. The meeting focused on strategic developments within the project, including progress in the implementation of key project activities, to ensure that national authorities and decision-makers are informed about project developments and are able to actively engage and provide strategic guidance within the implementation process.
GAB plays an important advisory role in supporting the implementation and sustainability of cancer screening initiatives within EUCanScreen. The Board brings together representatives from national Ministries of Health, cancer programmes, and other key bodies from each of 29 participating countries, providing a high-level platform for strategic dialogue and collaboration across Europe.
The agenda included presentations from project’s scientific leaders on key EUCanScreen activities and their development. Topics covered the Targeted Support Mechanism (TSM), which aims to strengthen governance and sustainability in cancer screening programmes through knowledge exchange and targeted support between participating countries, as well as the update of MAS-AI (Model for Assessing the Value of Artificial Intelligence), a tool designed to support informed decision-making regarding the adoption of AI solutions in healthcare.
The meeting also reviewed capacity-building activities, specifically for trainers, including the development of a training frameworks and programmes, as well as the delivery of Train-the-Trainer courses in specialised areas such as colposcopy. It also highlighted achievements and ongoing developments of risk-based cancer screening approaches. In addition, preparations for the upcoming Joint Stakeholder Conference, which will take place in Rome, were also discussed.
Board members actively participated in the meeting and expressed interest in the project’s developments and their potential impact at the national level by engaging in discussions, providing comments, and sharing feedback on the topics presented.
Meetings of the GAB are key to ensuring the active involvement of national authorities and decision-makers in EUCanScreen, thereby supporting coordinated implementation and the sustainable development and strengthening of cancer screening initiatives across their respective jurisdictions.
Views and opinions expressed are however those of the author(s) only and do not necessarily reflect those of the European Union or European Health and Digital Executive Agency (HaDEA). Neither the European Union nor HaDEA can be held responsible for them.
This website is managed by 6th DYPEDE, Greece.